{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T23:05:56.315026+00:00","published_at":"2026-10-16T13:53:16.622146+00:00","section":"board","data":{"state":"PUBLISHED","size":{"value":6,"assertion_class":"alpha_calculated_metric","basis":"Count of published current board seats in this Record. Roster completeness is not asserted.","input_claim_ids":["alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12"]},"chair":null,"lead_independent_director":null,"ceo_chair_combined":null,"independence":{"value":{"independent_directors":5,"directors_with_determination":6,"published_directors":6,"independent_share":0.833},"assertion_class":"alpha_calculated_metric","basis":"Board independence determinations are source facts; the share is computed only over directors with a published determination.","input_claim_ids":["alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12"]},"average_tenure_years":{"value":{"years":5.8,"directors_with_start_date":6},"assertion_class":"alpha_calculated_metric","basis":"Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.","input_claim_ids":["alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12"]},"committee_load":{"value":{"average_memberships":2.6,"directors_with_memberships":5},"assertion_class":"alpha_calculated_metric","basis":"Average published committee memberships per current director with at least one published membership.","input_claim_ids":["alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11"]},"skills_coverage":null,"directors":[{"person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa","canonical_url":"https://registry.alpha.ac/people/alaa-halawa"},"current_role":"Director","director_since":"2022-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2022-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa","canonical_url":"https://registry.alpha.ac/people/alaa-halawa"},"committee_id":"alpha:committee:neumora-therapeutics-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:17","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa","canonical_url":"https://registry.alpha.ac/people/alaa-halawa"},"committee_id":"alpha:committee:neumora-therapeutics-inc:compensation-nominating-and-governance-chair","committee_name":"Compensation; Nominating and Governance · Chair","role":"member","valid_from":"2022-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa","canonical_url":"https://registry.alpha.ac/people/alaa-halawa"},"committee_id":"alpha:committee:neumora-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:21","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Nominating and Governance"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:david-piacquad","name":"David Piacquad","canonical_url":"https://registry.alpha.ac/people/david-piacquad"},"current_role":"Director","director_since":"2023-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2023-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:david-piacquad","name":"David Piacquad","canonical_url":"https://registry.alpha.ac/people/david-piacquad"},"committee_id":"alpha:committee:neumora-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":"2023-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:13","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow","canonical_url":"https://registry.alpha.ac/people/kristina-burow"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow","canonical_url":"https://registry.alpha.ac/people/kristina-burow"},"committee_id":"alpha:committee:neumora-therapeutics-inc:compensation","committee_name":"Compensation","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:17","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow","canonical_url":"https://registry.alpha.ac/people/kristina-burow"},"committee_id":"alpha:committee:neumora-therapeutics-inc:compensation-chair-nominating-and-governance","committee_name":"Compensation · Chair; Nominating and Governance","role":"member","valid_from":"2020-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow","canonical_url":"https://registry.alpha.ac/people/kristina-burow"},"committee_id":"alpha:committee:neumora-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:21","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Compensation"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust","canonical_url":"https://registry.alpha.ac/people/matthew-fust"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust","canonical_url":"https://registry.alpha.ac/people/matthew-fust"},"committee_id":"alpha:committee:neumora-therapeutics-inc:audit","committee_name":"Audit","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:13","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust","canonical_url":"https://registry.alpha.ac/people/matthew-fust"},"committee_id":"alpha:committee:neumora-therapeutics-inc:audit-chair-compensation","committee_name":"Audit · Chair; Compensation","role":"member","valid_from":"2020-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust","canonical_url":"https://registry.alpha.ac/people/matthew-fust"},"committee_id":"alpha:committee:neumora-therapeutics-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:17","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Audit"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho","canonical_url":"https://registry.alpha.ac/people/maykin-ho"},"current_role":"Director","director_since":"2021-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2021-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho","canonical_url":"https://registry.alpha.ac/people/maykin-ho"},"committee_id":"alpha:committee:neumora-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:13","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho","canonical_url":"https://registry.alpha.ac/people/maykin-ho"},"committee_id":"alpha:committee:neumora-therapeutics-inc:audit-nominating-and-governance","committee_name":"Audit; Nominating and Governance","role":"member","valid_from":"2021-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho","canonical_url":"https://registry.alpha.ac/people/maykin-ho"},"committee_id":"alpha:committee:neumora-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:21","evidence_ids":["alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:paul-l-berns","name":"Paul L. Berns","canonical_url":"https://registry.alpha.ac/people/paul-l-berns"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a"],"assertion_class":"source_fact","verification_state":"source_reported"}],"fields_not_published":["chair","lead_independent_director","board_type","median_tenure","average_age","refreshment_rate","gender_diversity","geographic_diversity","succession_risk","overboarding","board_interlocks","attendance"]},"claims":[{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alaa-halawa","object_label":"Alaa Halawa","object_source_name_forms":[],"value":"Alaa Halawa: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-piacquad","object_label":"David Piacquad","object_source_name_forms":[],"value":"David Piacquad: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-piacquad","name":"David Piacquad"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kristina-burow","object_label":"Kristina Burow","object_source_name_forms":[],"value":"Kristina Burow: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-fust","object_label":"Matthew Fust","object_source_name_forms":[],"value":"Matthew Fust: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:maykin-ho","object_label":"Maykin Ho","object_source_name_forms":[],"value":"Maykin Ho: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-l-berns","object_label":"Paul L. Berns","object_source_name_forms":[],"value":"Paul L. Berns: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-l-berns","name":"Paul L. Berns"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:13","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Matthew Fust; Members Matthew Fust (Chair); David Piacquad; Maykin Ho","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Matthew Fust","members":[{"display_name":"Matthew Fust","person_slug":"matthew-fust","is_chair":true},{"display_name":"David Piacquad","person_slug":"david-piacquad","is_chair":false},{"display_name":"Maykin Ho","person_slug":"maykin-ho","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:17","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Kristina Burow; Members Kristina Burow (Chair); Alaa Halawa; Matthew Fust","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Kristina Burow","members":[{"display_name":"Kristina Burow","person_slug":"kristina-burow","is_chair":true},{"display_name":"Alaa Halawa","person_slug":"alaa-halawa","is_chair":false},{"display_name":"Matthew Fust","person_slug":"matthew-fust","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:21","subject_id":"alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Alaa Halawa; Members Alaa Halawa (Chair); Kristina Burow; Maykin Ho","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Alaa Halawa","members":[{"display_name":"Alaa Halawa","person_slug":"alaa-halawa","is_chair":true},{"display_name":"Kristina Burow","person_slug":"kristina-burow","is_chair":false},{"display_name":"Maykin Ho","person_slug":"maykin-ho","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Neumora Therapeutics, Inc. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:34:01.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.821,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.838,"cross_source_agreement":0.75,"temporal_completeness":0.4},"diagnostics":{"published_claims":24,"factual_claims":24,"claims_with_linked_evidence":24,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":15,"temporal_claims_with_valid_from":6,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:16.622146+00:00","observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":"2026-10-16T13:53:16.622146+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":24,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/neumora-therapeutics-inc/board","section":"board","href":"https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record&section=board","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}